1135P Comparison of Intracranial (IC) Response Assessment Criteria in Patients (pts) with Melanoma Brain Metastases (MBM) Treated with Combination Nivolumab (NIVO) Plus Ipilimumab (IPI) in CheckMate 204
Annals of Oncology(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要